Genomics · Genetic Reports · Precision Wellness
Medication Response Report
Personalized Genetic Report
Accession #: MRW-26-17176F
Report type: Full Report
Report status: FINAL
Specimen and client information
Specimen type
Buccal (cheek) swab
Date reported
29 July 2026
Panel
Medication Response Report
What this report covers
About this report
This report reads your DNA and sorts every result into one of five plain-language groups, so you can see at a glance what deserves attention and what does not. Nothing here is a diagnosis. A flagged result means your genetics place you above or below the average person for that trait — a reason to ask a question, not a reason to worry.
What each result group means
Worth a conversation with your doctor
These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
Running above the typical range
Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
Running below the typical range
Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Working in your favour
Good news. Your genetics look protective or better than average here.
In line with most people
Nothing unusual. These were tested and came back typical — worth having on record.
Your results at a glance
How to read this. A result being flagged does not mean you have a condition — it means your genetics put you above or below the average person for that trait. Of the 34 results here, 14 came back worth discussing with a clinician and 0 came back in your favour. Bring this document to your appointment.
Worth a conversation with your doctor (14)These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
From your Pharmacogenomics report
APhenprocoumon
Use with caution
Higher predisposition than average
AWarfarin
Use with caution
Higher predisposition than average
AAtorvastatin
Use with caution
Higher predisposition than average
AFluvastatin
Use with caution
Higher predisposition than average
ALovastatin
Use with caution
Higher predisposition than average
APitavastatin
Use with caution
Higher predisposition than average
APravastatin
Use with caution
Higher predisposition than average
ARosuvastatin
Use with caution
Higher predisposition than average
ASimvastatin
Use with caution
Higher predisposition than average
ADexlansoprazole
Use with caution
Higher predisposition than average
ALansoprazole
Use with caution
Higher predisposition than average
AOmeprazole
Use with caution
Higher predisposition than average
APantoprazole
Use with caution
Higher predisposition than average
AMethotrexate
Use with caution
Higher predisposition than average
Running above the typical range (0)Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
Running below the typical range (0)Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Working in your favour (0)Good news. Your genetics look protective or better than average here.
In line with most people (20)Nothing unusual. These were tested and came back typical — worth having on record.
From your Pharmacogenomics report
·Enflurane
Standard precautions
In line with the general population
·Halothane
Standard precautions
In line with the general population
·Isoflurane
Standard precautions
In line with the general population
·Methoxyflurane
Standard precautions
In line with the general population
·Sevoflurane
Standard precautions
In line with the general population
·Succinylcholine
Standard precautions
In line with the general population
·Acenocoumarol
Standard precautions
In line with the general population
·Clopidogrel
Standard precautions
In line with the general population
·Rabeprazole
Standard precautions
In line with the general population
·Allopurinol
Standard precautions
In line with the general population
·Capecitabine
Standard precautions
In line with the general population
·Fluorouracil
Standard precautions
In line with the general population
·Mercaptopurine
Standard precautions
In line with the general population
·Tegafur
Standard precautions
In line with the general population
·Azathioprine
Standard precautions
In line with the general population
·Siponimod
Standard precautions
In line with the general population
·Tacrolimus
Standard precautions
In line with the general population
·Voriconazole
Standard precautions
In line with the general population
·Efavirenz
Standard precautions
In line with the general population
·Nevirapine
Standard precautions
In line with the general population
Methodology
Genotyping was performed on DNA extracted from a buccal (cheek) swab using a genome-wide array. Results are derived from peer-reviewed genome-wide association data and, where applicable, published clinical guidelines. Each report was scored independently against its own reference set. Percentile figures describe where your result sits relative to a reference population.
Limitations
This is a laboratory-developed test. It has not been cleared or approved by the U.S. Food and Drug Administration. Genotyping does not detect all variants in the genes assessed; the absence of a flagged result does not exclude risk. Predisposition is probabilistic and is modified by environment, lifestyle, ancestry and family history. Results must be interpreted by a qualified healthcare professional and must not be used alone to diagnose, treat, or alter any medication regimen. Marrow does not recommend, prescribe, or dose any supplement or medication.
Performing laboratory & attestation
| Performing laboratory | Gene by Gene, Ltd. |
| Laboratory address | 1445 North Loop West, Suite 760, Houston, TX 77008 |
| CLIA certification | CLIA #45D1102202 |
| CAP accreditation | CAP #7212851 · accredited through 7 October 2027 |
| Laboratory Director | Feng Zhou, PhD, MB(ASCP) |
| Specimen type | Buccal (cheek) swab — genomic DNA |
| Accession | MRW-26-17176F |
| Date reported | 29 July 2026 |
This specimen was tested at Gene by Gene, Ltd., 1445 North Loop West, Suite 760, Houston, TX 77008, under CLIA #45D1102202 and CAP #7212851. Laboratory Director: Feng Zhou, PhD, MB(ASCP). Marrow Health is not a clinical laboratory and does not perform testing; Marrow prepares and delivers this report from data produced by the performing laboratory named above. Report generated 29 July 2026 · Accession MRW-26-17176F · © 2026 Marrow Health.